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ARTICLE
The Two ATP Binding Sites of Cystic Fibrosis Transmembrane 
Conductance Regulator (CFTR) Play Distinct Roles in Gating Kinetics 
and Energetics
Zhen Zhou,1,3 Xiaohui Wang,1,3 Hao-Yang Liu,2,3 Xiaoqin Zou,2,3 Min Li,1,3 
and Tzyh-Chang Hwang1,3
1Department of Medical Pharmacology and Physiology, 2Department of Biochemistry, 3Dalton Cardiovascular Research Center, 
University of Missouri-Columbia, Columbia, MO 65211
Cystic fi  brosis transmembrane conductance regulator (CFTR), a member of the ABC (ATP binding cassette) trans-
porter family, is a chloride channel whose activity is controlled by protein kinase–dependent phosphorylation. 
Opening and closing (gating) of the phosphorylated CFTR is coupled to ATP binding and hydrolysis at CFTR’s two 
nucleotide binding domains (NBD1 and NBD2). Recent studies present evidence that the open channel confor-
mation refl  ects a head-to-tail dimerization of CFTR’s two NBDs as seen in the NBDs of other ABC transporters 
(Vergani et al., 2005). Whether these two ATP binding sites play an equivalent role in the dynamics of NBD dimer-
ization, and thus in gating CFTR channels, remains unsettled. Based on the crystal structures of NBDs, sequence 
alignment, and homology modeling, we have identifi  ed two critical aromatic amino acids (W401 in NBD1 and 
Y1219 in NBD2) that coordinate the adenine ring of the bound ATP. Conversion of the W401 residue to glycine 
(W401G) has little effect on the sensitivity of the opening rate to [ATP], but the same mutation at the Y1219 resi-
due dramatically lowers the apparent affi  nity for ATP by >50-fold, suggesting distinct roles of these two ATP bind-
ing sites in channel opening. The W401G mutation, however, shortens the open time constant. Energetic analysis 
of our data suggests that the free energy of ATP binding at NBD1, but not at NBD2, contributes signifi  cantly to the 
energetics of the open state. This kinetic and energetic asymmetry of CFTR’s two NBDs suggests an asymmetric 
motion of the NBDs during channel gating. Opening of the channel is initiated by ATP binding at the NBD2 site, 
whereas separation of the NBD dimer at the NBD1 site constitutes the rate-limiting step in channel closing.
INTRODUCTION
As a member of the ABC transporter superfamily, cystic 
fi  brosis transmembrane conductance regulator (CFTR) 
has two nucleotide binding domains, NBD1 and NBD2 
(Riordan et al., 1989). For CFTR to function as a chloride 
channel, the CFTR protein needs to be phosphorylated 
in the regulatory (R) domain; subsequent interactions 
of ATP with the two NBDs control the opening and clos-
ing of the channel (i.e., gating). Several properties of 
CFTR’s two NBDs distinguish CFTR among members of 
the ABC family. First, CFTR’s two NBDs exhibit only mod-
erate sequence homology. Second, biochemical studies 
show that NBD2, but not NBD1, hydrolyzes ATP (Szabo 
et al., 1999; Aleksandrov et al., 2002; Basso et al., 2003). 
Third, NBD1 displays a higher ATP binding affi  nity 
than NBD2 (Szabo et al., 1999; Aleksandrov et al., 2001; 
Aleksandrov et al., 2002; Basso et al., 2003; Zhou et al., 
2005). Despite more than a decade of study, the func-
tional signifi  cance of this structural asymmetry of NBDs 
in CFTR gating remains unclear. It is generally agreed 
that ATP hydrolysis at NBD2 precedes channel closing 
since mutations (e.g., K1250A and E1371S) that abol-
ish ATP hydrolysis at the NBD2 site drastically prolong 
the open time (Carson et al., 1995; Gunderson and 
  Kopito, 1995; Zeltwanger et al., 1999; Vergani et al., 2003; 
  Bompadre et al., 2005b). However, recent studies suggest 
that ATP binding at NBD1 may also modulate the closing 
rate (Bompadre et al., 2005a,b; Zhou et al., 2005). How 
ATP binding catalyzes channel opening also remains un-
settled. One popular hypothesis is that ATP binding to 
both NBD1 and NBD2 is required for channel opening 
(Aleksandrov et al., 2001; Vergani et al., 2003; Berger 
et al., 2005; Vergani et al., 2005; for review see Gadsby 
et al., 2006). An alternative view is that ATP binding at 
NBD2 plays a major role in channel opening, whereas 
ATP binding at NBD1 may not be absolutely required 
for channel opening (Powe et al., 2002; Bompadre et al., 
2005b). One probable reason for these controversies is 
the fact that previous studies were mostly designed with 
limited structural information about CFTR’s NBDs. 
Very often, manipulations that affect ATP binding also 
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  perturb ATP hydrolysis (e.g., Gunderson and Kopito, 
1995; Basso et al., 2003; Vergani et al., 2003).
Ideally, to understand the roles of CFTR’s two NBDs, 
one needs to manipulate the ligand binding affi  nity at 
each NBD by mutating amino acid residues that interact 
with ATP in the binding pockets and/or by chemically 
engineering ATP to alter its affi  nity. These strategies 
have been successfully employed in other ATP binding 
proteins (e.g., Shah et al., 1997; Gillespie et al., 1999). 
Recent success in solving the crystal structures of CFTR’s 
NBD1 (Lewis et al., 2004; Lewis et al., 2005) and in 
  designing high-affi  nity hydrolyzable ATP analogues for 
CFTR gating (Zhou et al., 2005) has made structure-
guided functional studies possible for the fi  rst time in 
the CFTR fi  eld. A good example is the utilization of ho-
mology modeling of NBDs and mutant cycle analysis to 
demonstrate that the opening of the CFTR channels is 
associated with the dimerization of CFTR’s two NBDs 
(Vergani et al., 2005).
Capitalizing on the crystal structures of CFTR’s NBD1, 
we made mutations of the aromatic residues that inter-
act (or are predicted to interact) with the adenine ring 
of ATP in CFTR’s NBD1 (tryptophan 401, i.e., W401) 
and NBD2 (tyrosine 1219, i.e., Y1219). Macroscopic and 
microscopic kinetic analyses of ATP-dependent gating 
reveal functional asymmetry of these two ATP binding 
sites. Nonconserved mutations of Y1219 cause a right-
ward shift of the relationship between [ATP] and the 
opening rate, suggesting that ATP binding at the NBD2 
site plays a critical role in channel opening. Although 
conversion of W401 to glycine (i.e., W401G) has little 
effect on the sensitivity of the channel opening rate to 
[ATP], this mutation shortens the mean open time. The 
shortening of the open time by the W401G mutation 
is also seen with the hydrolysis-defi  cient mutant back-
ground (i.e., E1371S), suggesting that the effect of 
W401G mutation is not through a perturbation of ATP 
hydrolysis. Kinetic and energetic asymmetry of CFTR’s 
two ATP binding sites will be discussed.
MATERIALS AND METHODS
Transient Expression System
Wild-type (WT) or mutant CFTR channels were expressed tran-
siently in CHO cells. The cDNA constructs were cotransfected 
with pEGFP-C3 (CLONTECH Laboratories, Inc.), encoding the 
green fl  uorescent protein, using SuperFect transfection reagent 
(QIAGEN) according to manufacturer’s instruction. Electrophys-
iological recordings were performed 2–7 d after the transfection.
Electrophysiological Recordings
Inside-out patch-clamp recordings were performed according to 
methods described previously (e.g., Zhou et al., 2002). In brief, 
the pipette solution (i.e., extracellular solution) contained (in mM) 
140 NMDG-Cl, 2 MgCl2, 5 CaCl2, and 10 HEPES (pH 7.4 with 
NMDG). Cells were perfused with a bath solution containing 
(in mM) 145 NaCl, 5 KCl, 2 MgCl2, 1 CaCl2, 5 glucose, 5 HEPES, 
and 20 sucrose (pH 7.4 with NaOH). After the establishment of 
an inside-out confi  guration, the patch was perfused with a stan-
dard perfusion solution (i.e., intracellular solution) containing 
(in mM) 150 NMDG-Cl, 2 MgCl2, 10 EGTA, and 8 Tris (pH 7.4 
with NMDG). Patches were held at −50 mV in all experiments. 
Downward defl  ections of the current trace represent channel 
opening. Currents were recorded at room temperature using an 
EPC10 patch-clamp amplifi  er (Heka Electronic). Current traces 
were fi  ltered at 100 Hz with a built-in 4-pole Bessel fi  lter and digi-
tized online at 500 Hz.
Data Analysis
Steady-state macroscopic current amplitude, used for construc-
tion of the ATP dose–response relationship, was measured using 
Igor Pro program (version 4.07; Wavemetrics). Specifi  cally, the 
mean current amplitude was measured as an average of all data 
points from  1 min of continuous recording. The mean baseline 
current was measured in the same way and then subtracted. Only 
recordings from patches containing no more than eight channels 
(estimated from maximal number of simultaneous openings dur-
ing at least 20 min of recording) were selected for single-channel 
kinetic analysis. These data were further fi  ltered at 50 Hz and ana-
lyzed using software written by Dr. Csanády (2000). A three-state 
kinetic model, C↔O↔B, was adopted to extract kinetic parame-
ters as described previously (Csanády et al., 2000; Vergani et al., 
2003; Bompadre et al., 2005a). To estimate the time constant of 
current relaxation, a single exponential function was fi  tted to the 
data using Igor Pro program. The fi  rst 5 s of the current relax-
ation were excluded from curve fi  tting due to the limited speed of 
solution exchange.
All averaged data are presented as means ± SEM.; n represents 
the number of experiments. Student t tests were performed using 
SigmaPlot (version 8.0), and results were considered signifi  cant 
when P < 0.05.
Homology Modeling of Human CFTR NBD2
The modeled structure was generated by using the program 
MODELLER. The crystal structure of human F508A NBD1-ATP 
complexes (pdb code: 1xmi, chain A) was used as a template. 
Y1219 was aligned to W401 (also see Callebaut et al., 2004; 
  Moran et al., 2005). The ATP molecule was included in the 
  modeled structure.
Online Supplemental Material
The online supplemental material (text and Fig. S1) is available at 
http://www.jgp.org/cgi/content/full/jgp.200609622/DC1. The 
online supplement shows our energetic analysis of the closing 
rate for hydrolysis-defi  cient mutants.
RESULTS
The crystal structure of the NBD1 of human CFTR (Fig. 
1 A) reveals that W401 forms a ring–ring stacking inter-
action with the adenine ring of the bound ATP (Lewis 
et al., 2005). Sequence analyses suggest that Y1219 at 
NBD2 is the equivalent amino acid residue of W401 
(Fig. 1 B). The physiological importance of Y1219 in 
  coordinating ATP is implicated by the fact that Y1219 is 
perfectly conserved in CFTR from 36 different species. 
In fact, we collected 299 sequences of the ABC trans-
porter proteins from the gene bank; a tyrosine residue 
is found at the equivalent position in 86% of these pro-
teins (the rest are phenylalanine [12%], tryptophan 
[1%], and histidine [1%]). This is perhaps not surpris-
ing since the importance of aromatic residues in ligand   Zhou et al. 415
binding has been well established in other nucleotide 
binding proteins (e.g., Hung et al., 1998; Gillespie et al., 
1999; Hopfner et al., 2000; Huai et al., 2003, 2004; 
Zhang et al., 2004). Based on this sequence informa-
tion, we made a homology model of CFTR’s NBD2 us-
ing the coordinates of NBD1 as a template (Fig. 1 A).
To examine the role of ATP binding at CFTR’s two 
NBDs, we converted W401 or Y1219 to glycine and ex-
amined the effect of these mutations on the apparent 
affi   nity for ATP (K1/2). Wild-type (WT) and mutant 
CFTR channels in excised inside-out membrane patches 
were activated by the catalytic subunit of PKA plus ATP. 
Different concentrations of ATP were then applied to 
obtain a macroscopic ATP dose–response relationship. 
Fig. 1 C shows three representative traces. For WT chan-
nels, 0.1 mM ATP generates a CFTR activity about half 
of that with 2.75 mM ATP, a saturating concentration 
for WT CFTR gating (e.g., Zeltwanger et al., 1999). For 
the W401G mutant, 0.1 mM ATP elicits a similar level of 
activity. However, for the Y1219G mutant, 0.1 mM hardly 
induces any current different from the basal activity. 
Unlike WT and W401G, 2.75 mM ATP does not saturate 
Figure 1.  Tryptophan 401 and tyrosine 1219 residues interact with the adenine ring of ATP in the human CFTR NBD1 and NBD2, 
  respectively. (A) Interactions between ATP and key amino acids in the NBD1 binding pocket, adopted from the monomeric crystal 
structure of the human F508A NBD1-ATP complexes (pdb code: 1xmi, chain A) (left). A similar picture of modeled NBD2 binding 
pocket is shown on the right. Residues of interest are represented by sticks, including those that interact with adenine ring (W401 in 
NBD1 and Y1219 in NBD2), the Walker A lysines (K464 in NBD1 and K1250 in NBD2), and the catalytic Walker B glutamate residue, 
E1371. The protein backbone atoms are plotted in thin lines and colored in gray. The fi  gures were prepared by PYMOL. In other mem-
bers of the ABC family, there is either an E or a D at the position equivalent to E1371 of CFTR NBD2, however, it is a serine in CFTR’s 
NBD1 that is believed to be the structural basis for CFTR NBD1’s inability to hydrolyze ATP (Lewis et al., 2004; Lewis et al., 2005). Since 
ATP is found to be associated with the Walker A and B motifs in all crystal structures of NBDs resolved so far (e.g., Hung et al., 1998; 
  Karpowich et al., 2001; Yuan et al., 2001; Lewis et al., 2004), for the sake of clarity, we defi  ne the NBD1 ATP-binding site (or NBD1 site) 
as the binding pocket containing Walker A and Walker B motifs in the NBD1 sequence. An equivalent defi  nition is applied to the NBD2 
site. (B) Sequence alignment of the N-terminal part of the NBD1 and NBD2 of CFTR from 10 species (chosen randomly out of 36). 
  Aromatic residues studied in this paper are highlighted in yellow. Conserved residues are highlighted in gray. Note that a stretch of  30 
amino acids (from 404 to 435) is present in NBD1 (i.e., regulatory insertion) but absent in NBD2 (dashed line). (C) Representative 
bracketed current traces at different [ATP] for constructing ATP dose–response relationships. Current induced by various [ATP] 
was normalized to 2.75 mM ATP in the case of WT and W401G and to 20 mM ATP in the case of Y1219G. Horizontal bars represent 
50 s. (D) ATP dose–response relationships of WT (black), W401G (red), and Y1219G (green). Solid lines are Michaelis-Menten fi  ts to 
the data. The K1/2 values are 0.09 ± 0.02 mM, 0.11 ± 0.02 mM, and 4.72 ± 1.12 mM for WT, W401G, and Y1219G, respectively. Each data 
point represents the average from three to eight experiments.416 Gating of CFTR by Two ATP Binding Sites
the current for Y1219G (unpublished data). As seen in 
Fig. 1 C, 1 mM ATP, a concentration that induces  80% 
of maximal current for WT, only elicits a small fraction 
of current compared with that by 20 mM ATP, the highest 
[ATP] tested. Fig. 1 D summarizes normalized macro-
scopic ATP dose–response relationships of WT, W401G, 
and Y1219G. Although the W401G mutation does not 
affect the apparent affi  nity, converting Y1219 to glycine 
causes a dramatic rightward shift of the ATP dose–
  response curve with a K1/2 of 4.72 ± 1.12 mM, >50-fold 
higher than that of WT (0.09 ± 0.02 mM).
We further characterized several mutations at the 
Y1219 residue (Fig. 2 A). A more conserved mutation 
(Y1219W) does not change the K1/2 value signifi  cantly. 
The ATP dose–response relationships of Y1219F and 
Y1219I mutants lie between those of WT and Y1219G. 
These results suggest that observed changes of the ATP 
sensitivity are not due to a nonspecifi  c mutational effect. 
Since the macroscopic ATP dose–response mostly 
  refl  ects the potency of ATP in opening the channel, we 
hypothesize that ATP binding at the NBD2 site plays 
a critical role in channel opening.
To test this hypothesis, we examined single-channel 
kinetics of WT, W401G, and Y1219G. Fig. 2 B shows rep-
resentative single-channel traces. At 2.75 mM ATP, WT 
and W401G channels close for hundreds of millisec-
onds between opening bursts. However, even at 20 mM 
ATP, most of the closed events for Y1219G last for sev-
eral seconds. Since the opening rate of Y1219G is not 
saturated at 20 mM ATP, we also studied single-channel 
kinetics of Y1219I, which shows a smaller shift in the 
ATP dose–response relationship (Fig. 2 A). The rela-
tionship between the opening rate and [ATP] reaches a 
saturation at  10 mM ATP. The opening rate of Y1219I 
at 10 or 20 mM ATP is very similar to that of WT at 2.75 
mM ATP (Fig. 2, B and C), indicating that mutations at 
the Y1219 residue likely affect the ATP binding step 
with minimal effect on the post-binding events. Fig. 2 C 
shows the relationship between the opening rate and 
[ATP] for WT, W401G, Y1219I, and Y1219G. It should 
be noted that these relationships virtually mirror the 
macroscopic ATP dose–response relationship (Fig. 2 A), 
consistent with the notion that the opening rate is the 
major determinant for the macroscopic ATP dose–
  response curve (Zeltwanger et al., 1999; Powe et al., 
2002; Vergani et al., 2003).
It is known that the opening rate of CFTR is very sen-
sitive to the infl  uence of PKA-dependent phosphoryla-
tion (Mathews et al., 1998; Wang et al., 1998). Before we 
draw the conclusion that these mutational effects at the 
Y1219 residue result from a perturbation of ATP bind-
ing at the NBD2 site, we need to rule out the possibility 
that mutations at the Y1219 residue somehow hinder 
phosphorylation of the R domain, and thus the ob-
served decrease of the opening rate is secondary to a 
potential mutational effect on phosphorylation. To ex-
clude this possibility, we introduced the mutations of 
  interest into a CFTR construct with the entire R domain 
Figure 2.  Effects of mutations at 
W401 and Y1219 on the opening rate. 
(A) Normalized ATP dose–response 
  relationships of WT (black line, 
  Michaelis-Menten fi   t from Fig. 1 D), 
Y1219W (brown), Y1219F (pink), 
Y1219I (blue), and Y1219G (green line, 
Michaelis-Menten fi   t from Fig. 1 D). 
Solid lines are the Michaelis-Menten fi  ts 
to the data. K1/2 values are 0.13 ± 
0.02 mM (Y1219W), 0.46 ± 0.06 mM 
(Y1219F), and 0.94 ± 0.20 mM 
(Y1219I), respectively. (B) Represen-
tative single-channel current traces of 
WT, W401G, Y1219G, and Y1219I 
in   response to [ATP] as marked. 
(C)   Relationships between channel 
opening rates and [ATP] for WT 
(black), W401G (red), Y1219I (blue), 
and Y1219G (green). Solid lines are 
  Michaelis-Menten fi  ts to the data of WT 
(black) and Y1219I (blue). The maxi-
mal opening rate and K1/2 values are 
2.42 ± 0.11 s−1 and 0.11 ± 0.02 mM for 
WT, and 2.60 ± 0.11 s−1 and 1.73 ± 
0.26 mM for Y1219I, respectively. 
(D) Relationships between channel 
opening rates and [ATP] for ∆R-CFTR 
(black), ∆R-Y1219I (blue), and ∆R-Y1219G (green). K1/2 from Michaelis-Menten fi  ts (solid lines) are 0.16 ± 0.04 mM and 1.27 ± 0.16 
mM for ∆R-CFTR and ∆R-Y1219I,   respectively. (Data for ∆R-CFTR were obtained from Bompadre et al., 2005a.)  Zhou et al. 417
deleted (∆R-CFTR) (Csanády et al., 2000). We have ex-
tensively characterized this phosphorylation-independent 
CFTR channel and shown that its ATP sensitivity and 
single-channel kinetic parameters are very similar to 
those of WT CFTR (Bompadre et al., 2005a). Fig. 2 D 
shows a similar rightward shift of the ATP dose–response 
relationships for Y1219I and Y1219G mutants under the 
∆R-CFTR background. These results strongly support 
the hypothesis that ATP binding at the NBD2 site cata-
lyzes channel opening.
Although mutations of the W401 residue at the NBD1 
site had minimal effect on the relationship between 
[ATP] and the opening rate (Fig. 2, B and C), close in-
spection of the single-channel current trace reveals that 
the channel open time is shorter for the W401G mutant 
(Fig. 2 B). Fig. 3 A summarizes the mean open time for 
WT, W401G, and Y1219G. Although the Y1219G muta-
tion causes a dramatic change of the relationship be-
tween [ATP] and the opening rate, it has negligible 
effect on the mean open time. In contrast, W401G ex-
hibits  40% decrease of the mean open time, suggest-
ing that mutations that decrease the ATP binding 
affi  nity at the NBD1 site destabilize the open channel 
conformation (i.e., increase the closing rate). It should 
be noted that this shortening of the mean open time by 
W401G mutant is not readily refl  ected in the ATP dose–
response relationship (Fig. 1 D). Indeed, according to 
our simulation, if the relationship between the opening 
rate and [ATP] remains unchanged, a 40% shortening 
of the mean open time only results in  15% change of 
the apparent Kd, which is within the experimental error 
range (Fig. 1 D, legend).
We considered three possibilities for the shortened 
open time seen with the W401G mutation at NBD1. 
First, since it is established that ATP hydrolysis at NBD2 
leads to channel closing during the ATP hydrolysis–
driven gating cycle, it is possible that the W401G muta-
tion accelerates the ATP hydrolysis rate of NBD2. 
Second, it has been demonstrated that the open state of 
the channel corresponds to a dimer conformation of 
NBDs (Vergani et al., 2005), and the two ATP molecules 
are sandwiched at the dimer interface as shown in other 
ABC family members (Smith et al., 2002; Chen et al., 
2003). If this were the case, the binding energy of ATP 
could contribute to the overall stability of the dimer 
(or open state). It is probable then that mutating W401 
in NBD1 decreases the binding energy of ATP so that 
the resulting dimer, thus the open state, becomes less 
stable. Third, the shortened open time of the W401G 
could be due to an allosteric effect.
To examine the potential effect of mutation in NBD1 
on ATP hydrolysis at NBD2, we introduced the W401G 
mutation into the E1371S background, a mutant CFTR 
whose ATP hydrolysis is abolished (Moody et al., 2002; 
Tombline et al., 2004; Vergani et al., 2005). If the short-
ened open time seen with the W401G mutant is indeed 
due to an increased ATP hydrolysis rate, the effect on 
the open time should be at least reduced once the ATP 
hydrolysis is eliminated. Since the gating cycle of chan-
nels in the E1371S background is extremely long, it is 
technically diffi  cult to do microscopic single-channel 
kinetic analysis. We, therefore, resorted to macroscopic 
current relaxation experiments, which has been used 
previously to assess the mean open time of hydrolysis-
defi  cient CFTR channels (Vergani et al., 2003, 2005; 
Bompadre et al., 2005a). It should be noted that the re-
laxation time constant upon withdrawal of ATP is deter-
mined by the channel closing rate, opening rate, and 
the ATP dissociation rate if a simply ligand-gated kinetic 
scheme is assumed. However, since the ATP dissocia-
tion rate is much faster than the channel opening rate 
and closing rate, this relaxation time constant refl  ects 
Figure 3.  Effect of mutations 
at W401 and Y1219   residues 
on channel open time. (A) 
Mean open times of WT and 
W401G in the presence of 
2.75 mM ATP are 441.3 ± 
49.4 ms (n = 13) and 248.7 ± 
11.3 ms (n  = 22), respec-
tively. The mean open time 
of Y1219G in the presence 
of 20 mM ATP is 399.1 ± 
40.4 ms (n = 5). *** indicates 
P < 0.001 between WT and 
W401G. (B) Representative 
current relaxation traces 
upon withdrawal of 1 mM 
ATP plus PKA for E1371S, 
W401G/E1371S, triple/
E1371S, Y1219G/E1371S, 
and W401G/Y1219G/E1371S. 
Solid lines above the traces indicate the duration of application of 1 mM ATP plus PKA. Horizontal scale bars represent 200 s. (C) Mean relax-
ation time constants upon withdrawal of 1 mM ATP plus PKA. ** indicates P < 0.01 and *** indicates P < 0.001 (compared with E1371S).418 Gating of CFTR by Two ATP Binding Sites
mainly the closing rate of the channel (see online sup-
plemental material for detail, available at http://www.
jgp.org/cgi/content/full/jgp.200609622/DC1). Fig. 3 B 
shows experiments using current relaxation analysis to 
estimate the open time constants for E1371S and 
W401G/E1371S. Our results show that the relaxation 
time constant for W401G/E1371S (59.1 ± 4.6 s, n = 8) 
is shortened by  50%, compared with that of E1371S 
(111.7 ± 12.1 s, n = 15) (Fig. 3 C), suggesting that the 
shorter open time of W401G is not secondary to an al-
tered ATP hydrolysis rate. In contrast, although the 
Y1219G mutation greatly decreases the apparent affi  n-
ity of ATP (Fig. 2 C), introducing this mutation into the 
E1371S background has little effect on the relaxation 
time constant (107.6 ± 12.4 s, n = 7) (Fig. 3, B and C). 
In addition, W401G/Y1219G/E1371S has a relaxation 
time constant of 49.0 ± 5.3 s (Fig. 3, B and C), which is 
similar to that of W401G/E1371S, indicating that W401, 
but not Y1219, plays a dominant role in modulating the 
open time.
Although we cannot rule out the possibility of an al-
losteric effect of mutations on the stability of the open 
state, the following results are more in line with the 
idea that it is the binding energy of ATP that deter-
mines the stability of the open state. First, it has been 
shown that mutations at the K464 residue (Fig. 1 A) de-
crease ATP binding affi  nity at the NBD1 site (Basso 
et al., 2003) and shorten the open time (Carson et al., 
1995; Gunderson and Kopito, 1995; Sugita et al., 1998; 
Powe et al., 2002; compare with Vergani et al., 2003). 
Second, we have recently characterized the effects of 
an ATP analogue, N6-(2-phenylethyl)-ATP (denoted as 
P-ATP), on CFTR gating. Not only is P-ATP >50-fold 
more potent than ATP in opening CFTR, it also in-
creases the open time by  30% (Fig. 4 A; also see Zhou 
et al., 2005). Third, the shortened relaxation time con-
stant due to the W401G mutation can be prolonged by 
P-ATP (see below).
The idea that ATP binding at the NBD1 site stabilizes 
the open channel conformation is also supported by 
the recent report by Csanády et al. (2005) An interest-
ing feature revealed by the comparison of NBD1 and 
NBD2 sequences (Fig. 1 B) is that NBD1 has a “regula-
tory insertion” consisting of amino acids 404–435 (Lewis 
et al., 2004, 2005). Deletion of part of this regulatory 
  insertion destabilizes the open state (Csanády et al., 
2005). Interestingly, two additional aromatic amino acids 
(F409 and F430) are located in this regulatory insertion. 
  Furthermore, the crystal structure of NBD1 from mouse 
CFTR shows interactions between ATP and all three 
amino acids including W401, F409 (leucine in the mouse 
NBD1), and F430. Since multiple aromatic amino acids 
can be used to form a high affi  nity nucleotide binding 
pocket (e.g., Gillespie et al., 1999; Huai et al., 2003, 2004), 
we further examine the contribution of F409 and F430 in 
stabilizing the open state.
We converted all three aromatic amino acids, includ-
ing W401, F409, and F430 to glycine in the E1371S 
background and examined current relaxations of the 
W401G/F409G/F430G/E1371S (or triple/E1371S). 
Compared with the current relaxation of W401G/
E1371S (Fig. 3 B), the triple/E1371S mutation further 
shortens the time course of current decay. Thus the re-
laxation time constants show a graded change as addi-
tional mutations in NBD1’s ATP binding pocket were 
introduced (Fig. 3 C). The simplest interpretation of 
these results is that these three aromatic amino acids 
contribute to the stability of the open state by stabilizing 
ATP binding at the NBD1 site.
To further examine the role of ligand binding in 
  stabilizing the open state, we considered nucleoside tri-
phosphates that have been characterized previously, 
such as GTP, CTP, UTP (Zeltwanger, 1998), and P-ATP 
(Zhou et al., 2005). Unlike GTP, CTP, and UTP, which 
only change the apparent affi  nity modestly, P-ATP has 
an apparent affi  nity >50-fold of that for ATP. We thus 
consider P-ATP an ideal ATP analogue for this type of 
energetic analysis. If the hypothesis that ligand binding 
energy can contribute to the stability of the open state is 
correct, one would expect that P-ATP should prolong 
the open time constant (Fig. 4 A). Fig. 4 B shows experi-
ments examining current relaxations upon removal of 
ATP or P-ATP for E1371S, W401G/E1371S, Y1219G/
E1371S, and triple/E1371S. As demonstrated previously 
(Zhou et al., 2005), the relaxation time course upon 
washout of P-ATP for E1371S is approximately twofold 
longer than that with ATP. P-ATP also increases the relax-
ation time constant of Y1219G/E1371S by approximately 
twofold. However, this prolongation effect of P-ATP is 
signifi   cantly larger for W401G/E1371S (2.7-fold) and 
  triple/E1371S (greater than fourfold; Fig. 4 C). These 
data suggest an energetic coupling between mutations at 
the NBD1 site and alterations of the bound ligand. On the 
other hand, mutating the NBD2 residue and changing of 
the binding energy of the ligand are two independent 
events (see online supplemental material for detailed 
analysis). We thus propose that ligand binding at the 
NBD1 site stabilizes the open state.
DISCUSSION
Gating of the CFTR chloride channel is unique in that 
the ligand ATP, used for opening the channel, is hydro-
lyzed. Studies using different mutations that perturb 
ATP hydrolysis (e.g., K1250A, E1371S) indicate that 
ATP hydrolysis drives channel closure. This input of the 
free energy of ATP hydrolysis into gating transitions 
poses great challenges in understanding CFTR’s gating 
mechanism since it is often diffi  cult to separate the 
functional roles of ATP binding and ATP hydrolysis in 
CFTR gating. Previous mutagenesis approaches to 
studying ATP-dependent gating focus on amino acid   Zhou et al. 419
residues located in the well-conserved motifs (e.g., 
K464, K1250 in Walker A and D572, D1370, E1371 in 
Walker B motifs). These residues are conserved because 
they interact with the phosphate groups and Mg ions in 
the ATP binding pockets. Although these studies have 
provided signifi  cant insight into the role of ATP hydro-
lysis in CFTR gating, this kind of approach does not pro-
vide a distinct advantage in understanding the role of 
ATP binding since altering the ligand binding affi  nity 
with these mutations is often complicated by the 
  mutational effect on ATP hydrolysis (e.g., K1250A in 
Vergani et al., 2003).
Recent successes in solving the crystal structures of 
CFTR’s NBD1 (Lewis et al., 2004, 2005) have laid the 
foundation for a new era of gating studies using structure-
guided mutagenesis approaches. The crystal structure 
of human CFTR’s NBD1 reveals that the side chain 
of the W401 residue forms ring–ring stacking inter-
action with the adenine ring of the bound ATP mol-
ecule.   Previous studies of other ATP binding proteins 
(MacLeod et al., 1998; Zhao and Chang, 2004; compare 
with   Shyamala et al., 1991) suggest that aromatic amino 
acids that interact with the adenine ring of ATP may 
be the ideal candidates for investigating the role of 
ATP binding. Although the crystal structure of CFTR’s 
NBD2 has yet to be solved, using sequence analysis and 
homology modeling, we identifi  ed the Y1219 residue 
as the equivalent amino acid at the NBD2 site that in-
teracts with the adenine ring of ATP (Fig. 1). A model 
by H. Senderowitz and collaborators from Predix Phar-
maceuticals also reveals the same role of Y1219 in ATP 
binding (personal communication). Functional studies 
of the Y1219 mutations indeed suggest a critical role 
of this residue in channel opening (Figs. 1 and 2). The 
Y1219I mutation lowers the sensitivity of the opening 
rate to [ATP] without altering the maximal opening rate 
(Fig. 2), indicating that this mutation indeed   decreases 
the binding affi  nity for ATP at the NBD2 site. Interest-
ingly, although the Y1219G mutation causes a drastic 
shift of the ATP dose–response relationship (Figs. 1 and 
2), it does not affect the mean open time. If we accept 
the idea that the open time is determined by the rate 
of ATP hydrolysis (Gadsby et al., 2006), this latter re-
sult suggests that the mutations at the Y1219 residue 
preferentially decrease ATP binding affi  nity without a 
signifi  cant effect on ATP hydrolysis. Thus, these novel 
mutations investigated in this paper could be useful 
tools to discern the roles of ATP binding for future 
CFTR gating studies.
Although the crystal structure of human CFTR’s 
NBD1 reveals the importance of W401 in ATP binding 
at the NBD1 site, the W401 mutation does not affect the 
ATP dose–response relationship, an inexact but direct 
way to estimate changes of ATP binding affi  nity. This 
negative result presents challenges for one to quanti-
tatively gauge ATP–NBD1 interactions. Our energetic 
analysis shown in the supplemental material, albeit 
imperfect and with its own assumptions, provides a po-
tential quantitative assay to assess the functional conse-
quence of mutations that decrease ATP binding affi  nity 
at the NBD1 site. Using this analysis, we show that two 
additional aromatic amino acids (F409 and F430) also 
play a role in determining the closing rate. It should 
be noted that F409 and F430 are found to interact with 
ATP in the crystal structure of mouse NBD1, but not 
Figure 4.  Effects of P-ATP on the relaxation time constant. 
(A) Two representative single-channel current traces of WT-CFTR 
in the presence of P-ATP (red) or ATP (black). The mean open 
time for P-ATP or ATP opened channels are 583.9 ± 60.6 ms (n = 6) 
and 441.3 ± 49.4 ms (n = 13), respectively. (B) Representative 
current relaxation traces of E1371S, W401G/E1371S, triple/
E1371S, and Y1219G/E1371S after withdrawal of 1 mM ATP plus 
PKA or 50 μM P-ATP plus PKA. Horizontal scale bars represent 
200 s. (C) The ratio of the relaxation time constant upon with-
drawal of 50 μM P-ATP plus PKA to that upon withdrawal of 1 mM 
ATP plus PKA from the same patch was calculated for E1371S and 
various mutants in the E1371S background. The mean values are 
taken from 3–11 experiments. *** indicates P < 0.001 and 
**** indicates P < 0.0001 (compared with E1371S).420 Gating of CFTR by Two ATP Binding Sites
human NBD1. The reason for this discrepancy is un-
clear. But X-ray crystallography provides only static snap-
shots of protein structures. Moreover, the numerous 
artifi  cial mutations introduced into human CFTR’s 
NBD1 for optimal crystallization may cause distortion 
of the structure. A more interesting possibility is that 
these minor differences in the binding pocket for the 
adenine ring of ATP may refl  ect different NBD1 struc-
tures in different functional states. Future studies 
of CFTR gating using these mutations may provide 
  defi  nitive answers.
The current studies of mutations in CFTR’s ATP bind-
ing pockets suggest that the two ATP binding sites differ 
in their gating functions both kinetically and energetically. 
Since the closed state of the channel represents NBDs 
in the monomeric confi  guration (Vergani et al., 2005), 
the relationship between [ATP] and the opening rate 
refl  ects the ATP binding affi  nity at the site that controls 
channel opening. Our results with the Y1219 and W401 
mutations (Fig. 2 C) suggest that ATP binding at the 
NBD2 site, but not the NBD1 site, is critical for channel 
opening. However, whether ATP binding at the NBD1 
site is essential for channel opening (e.g., Vergani et al., 
2003) remains unknown. On the other hand, although 
both ATP binding sites play a role in channel closing, 
each site utilizes ATP differently. During normal hydro-
lysis-driven gating, it appears that it is the ATP hydroly-
sis at the NBD2 site that catalyzes channel closing 
(Carson et al., 1995; Zeltwanger et al., 1999; Vergani 
et al., 2003; Bompadre et al., 2005b), whereas ATP bind-
ing at the NBD1 site modulates the closing rate by stabi-
lizing the open channel conformation.
The kinetic and energetic asymmetry in CFTR’s NBDs 
described above imparts several structural and biochem-
ical implications. First, we propose an asymmetrical mo-
lecular motion of NBDs during gating. Our results 
suggest that channel opening is initiated by ATP bind-
ing at the NBD2 site. Indeed, the critical pair of amino 
acids (R555 and T1246 in Vergani et al., 2005) identifi  ed 
for lowering the transitional state energy for NBD di-
merization is absent in the NBD1 site (T460 and L1353). 
Thus, it is possible that the molecular motion of NBD 
dimerization that leads to opening of the gate may not 
proceed as a simple symmetrical movement of two ATP-
bound NBDs. We propose that NBD dimerization is trig-
gered by ATP binding at the NBD2 site and subsequently 
progresses to close the gap at the NBD1 site. Since the 
open state represents a head-to-tail dimer of CFTR’s two 
NBDs with two ATP molecules sandwiched in between, 
the ligand ATP now becomes part of the whole protein 
molecule in the open channel confi  guration. Thus, the 
ligand binding energy is expected to be part of the over-
all energetics of the open channel conformation. This 
idea predicts that manipulating the ligand binding en-
ergy with mutations or alterations of ligands can affect 
the stability of the open state. It seems puzzling that 
  mutations at the NBD1 site, but not the NBD2 site, affect 
the open time. However, these results are consistent with 
the idea that separation of the NBD dimer at the NBD1 
site is coupled to channel closing (compare Vergani 
et al., 2003). Taking one step further, we speculate that 
the molecular motion that couples NBD dimerization 
and opening of the gate resides in the NBD1 site.
Second, it is known that NBD1 does not hydrolyze 
ATP (Szabo et al., 1999; Aleksandrov et al., 2002; Basso 
et al., 2003). Unlike the NBD2 site, the ATP binding 
pocket at NBD1 lacks the crucial glutamate residue that 
serves as a catalytic base for ATP hydrolysis (Lewis et al., 
2004, 2005). In addition, the Walker A lysine (K464 in 
human CFTR) is not perfectly conserved across species. 
If the hypothesis that the free energy of ATP binding at 
the NBD1 site is used to stabilize the open channel con-
fi  guration is correct, it is perhaps not surprising that the 
NBD1 site is not designed to hydrolyze ATP.
Third, to harvest a high binding energy at NBD1, it is 
necessary to construct a binding pocket that binds ATP 
tightly. It is interesting to note that the two aromatic 
residues, F409 and F430, in the ATP binding pocket of 
the NBD1 site, are located in the regulatory insertion 
that is unique to CFTR’s NBD1. The existence of multi-
ple aromatic residues in ATP binding pockets have been 
reported previously in many ATP binding proteins with 
high affi  nity to nucleotides, such as phosphodiesterases 
(Huai et al., 2003, 2004) and myosin isozymes (Gillespie 
et al., 1999). It is tempting to speculate that the higher 
affi  nity for nucleotides in NBD1 compared with NBD2 
(Szabo et al., 1999; Aleksandrov et al., 2001; Aleksandrov 
et al., 2002; Basso et al., 2003; Zhou et al., 2005) is at 
least partly due to the existence of multiple aromatic 
residues in the ATP binding pocket of NBD1.
Regardless of how NBD1 assumes a high affi  nity for 
ATP, given the fact that the intracellular [ATP] is nearly 
always maintained in the millimolar range, it seems puz-
zling why one of CFTR’s two NBDs (i.e., NBD1) exhibits 
a higher affi  nity for ATP, while most of the other ABC 
family members have two very similar NBDs. If we ac-
cept that CFTR is evolved from a primordial ABC trans-
porter that functions as an ATP hydrolysis–driven pump, 
this structural modifi  cation of CFTR’s NBD1 may serve 
a teleological purpose. For a pump molecule to trans-
port its substrate effi  ciently, it is preferable for most of 
the intermediate states during a transport cycle to be 
short-lived. This basic design principle for effi  cient 
pumps may not be ideal for a channel because only the 
open state of the channel conducts ions. It seems possi-
ble that the purpose of rendering NBD1 with a high af-
fi  nity for ATP is to allow the channel to stay in the open 
state longer so that more Cl− ions can go through the 
channel during each gating cycle.
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